Niti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...

The Trinamool Congress has escalated its offensive against rebel leader Ritabrata Banerjee, with a party spokesperson urging government act...

Honasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...

Late industrialist T. T. Jagannathan, the visionary behind the Gasket Release System that revolutionized pressure cooker safety, will be ho...

UAE immigration authorities have streamlined visa validity checks via online platforms, a crucial service amid a 30-day grace period ending...

The Bombay High Court has cancelled Thane-based Menschlich Healthcare's trademark 'Duphachrit' in favour of Abbott Product Operations AG. T...

Fund Manager Christy Mathai sees easing war-driven inflation fears, expecting a shorter earnings hit. He's selectively adding to his portfo...

Bank of Baroda has broken out of a consolidation range with bullish technical indicators, including a weekly bullish engulfing pattern and ...

Approximately $26 billion in shares from 71 recently listed companies will become available for sale as IPO lock-ins expire between June 17...

Indian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...

Rising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...

Jio Platforms has surged into the global top 20 of WIPO's PCT rankings, a remarkable leap of 320 positions. This achievement highlights Jio...

India's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...

AstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...

Hyderabad's Hetero Labs partners with European giant Gedeon Richter. They will jointly develop and sell Semaglutide Injection, the generic ...

India's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...

Alkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...